Biosimilar insulins: a potential option in the treatment of Diabetes
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Autor Principal: | |
|---|---|
| Outros autores: | |
| Formato: | Thesis |
| Idioma: | English |
| Publicado: |
Brac University
2022
|
| Subjects: | |
| Acceso en liña: | http://hdl.handle.net/10361/15923 |
| id |
10361-15923 |
|---|---|
| record_format |
dspace |
| spelling |
10361-159232022-01-16T21:01:34Z Biosimilar insulins: a potential option in the treatment of Diabetes Tabassum, Turana Kabir, Eva Rahman Department of Pharmacy, Brac University Diabetes Biologics Biosimilar insulin Insulin approval Interchangeability Insulin glargine Diabetes--Treatment This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 75-89). Diabetes is one of the most common noncommunicable diseases in the world and insulin, a biologic, has been a successful treatment option for this disease. However, the cost of insulin treatment is expensive and thus a global burden. The introduction of biosimilar insulins (a highly similar copy of the biologic insulin) will not only reduce the cost but will also open door to patient access and choices of diabetes treatment. Several biosimilar insulins are already available in the market, and patient acceptability is expected to increase over time. Different countries with their stringent laws are working to establish this treatment option for the diabetic patients. A greater knowledge for the acceptance of biosimilar insulins is needed for the biosimilar insulin to be used in place of the biologic insulin. This paper aims to provide an overview on biosimilar insulins as a potential option for the treatment of diabetes. Turana Tabassum B. Pharmacy 2022-01-16T05:43:30Z 2022-01-16T05:43:30Z 2021 2021-04 Thesis ID 17346050 http://hdl.handle.net/10361/15923 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 89 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Diabetes Biologics Biosimilar insulin Insulin approval Interchangeability Insulin glargine Diabetes--Treatment |
| spellingShingle |
Diabetes Biologics Biosimilar insulin Insulin approval Interchangeability Insulin glargine Diabetes--Treatment Tabassum, Turana Biosimilar insulins: a potential option in the treatment of Diabetes |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. |
| author2 |
Kabir, Eva Rahman |
| author_facet |
Kabir, Eva Rahman Tabassum, Turana |
| format |
Thesis |
| author |
Tabassum, Turana |
| author_sort |
Tabassum, Turana |
| title |
Biosimilar insulins: a potential option in the treatment of Diabetes |
| title_short |
Biosimilar insulins: a potential option in the treatment of Diabetes |
| title_full |
Biosimilar insulins: a potential option in the treatment of Diabetes |
| title_fullStr |
Biosimilar insulins: a potential option in the treatment of Diabetes |
| title_full_unstemmed |
Biosimilar insulins: a potential option in the treatment of Diabetes |
| title_sort |
biosimilar insulins: a potential option in the treatment of diabetes |
| publisher |
Brac University |
| publishDate |
2022 |
| url |
http://hdl.handle.net/10361/15923 |
| work_keys_str_mv |
AT tabassumturana biosimilarinsulinsapotentialoptioninthetreatmentofdiabetes |
| _version_ |
1814307800841453568 |